0001161697-24-000253.txt : 20240605
0001161697-24-000253.hdr.sgml : 20240605
20240605170021
ACCESSION NUMBER: 0001161697-24-000253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harper Molly
CENTRAL INDEX KEY: 0001871470
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 241022810
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 06-03-2024
X0508
4
2024-06-03
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001871470
Harper Molly
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
1
0
0
0
0
Common Stock, par value $0.001 per share
2024-06-03
4
S
0
5333
16.304
D
0
D
Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Harper remains a director of the Company.
Represents a weighted average price for the shares sold. Shares were sold in a range between $16.26 and $16.34 per share.
/s/ Molly Harper
2024-06-05